![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-021-05726-x/MediaObjects/11695_2021_5726_Fig1_HTML.png)
References
Camilleri M. Diabetic Gastroparesis. N Engl J Med. 2007;356(8):820–9. https://doi.org/10.1056/NEJMcp062614.
Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127(5):1589–91. https://doi.org/10.1053/j.gastro.2004.09.054.
Ye Y, Jiang B, Manne S, Moses PL, Almansa C, Bennett D, Dolin P, Ford AC. Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom. Gut. 2020. https://doi.org/10.1136/gutjnl-2020-321277.
Boaz M, Kislov J, Dickman R, Wainstein J. Obesity and symptoms suggestive of gastroparesis in patients with type 2 diabetes and neuropathy. J Diabetes Complications. 2011;25(5):325–8. https://doi.org/10.1016/j.jdiacomp.2011.06.005.
Papasavas PK, Ng JS, Stone AM, Ajayi OA, Muddasani KP, Tishler DS. Gastric bypass surgery as treatment of recalcitrant gastroparesis. Surg Obes Relat Dis. 2014;10(5):795–9. https://doi.org/10.1016/j.soard.2014.01.013.
Zehetner J, Ravari F, Ayazi S, Skibba A, Darehzereshki A, Pelipad D, Mason RJ, Katkhouda N, Lipham JC. Minimally invasive surgical approach for the treatment of gastroparesis. Surg Endosc. 2013;27(1):61–6. https://doi.org/10.1007/s00464-012-2407-0.
Landreneau JP, Strong AT, El-Hayek K, Kroh MD, Rodriguez JH. Gastrectomy versus stomach left in situ with Roux-en-Y reconstruction for the treatment of gastroparesis. Surg Endosc. 2020;34(4):1847–55. https://doi.org/10.1007/s00464-019-06951-3.
Sun Z, Rodriguez J, McMichael J, Chand B, Nash D, Brethauer S, Schauer P, El-Hayek K, Kroh M. Surgical treatment of medically refractory gastroparesis in the morbidly obese. Surg Endosc. 2015;29(9):2683–9. https://doi.org/10.1007/s00464-014-3990-z.
Wakamatsu K, Perez Quirante F, Montorfano L, Lo Menzo E, Seto Y, Rosenthal RJ. Laparoscopic treatment of gastroparesis: a single center experience. Surg Obes Relat Dis. 2018;14(2):200–5. https://doi.org/10.1016/j.soard.2017.07.029.
Salameh JR, Schmieg RE Jr, Runnels JM, Abell TL. Refractory gastroparesis after Roux-en-Y gastric bypass: surgical treatment with implantable pacemaker. J Gastrointest Surg. 2007;11(12):1669–72. https://doi.org/10.1007/s11605-007-0331-8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
The patient gave informed consent to the anonymous publication of her medical data. Study registration number: 2021-A01441-40.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• Gastroparesis may be refractory to treatment including gastric electrical stimulation in patients with diabetes mellitus type 1 and obesity
• Compared to gastrectomy as a treatment for refractory gastroparesis, Roux-Y reconstruction with stomach left in situ (similar to gastric bypass) is a less extensive surgery and requires less operative time
• Roux-en-Y gastric bypass with maintenance of the gastric pacemaker in the remnant stomach is a feasible and safe procedure
Supplementary Information
Rights and permissions
About this article
Cite this article
Hage, M., Bouche, C., Coffin, B. et al. Maintenance of a Gastric Pacemaker in the Excluded Stomach During a Roux-en-Y Gastric Bypass Procedure in a Patient with Obesity, Type 1 Diabetes and Refractory Gastroparesis. OBES SURG 31, 5497–5499 (2021). https://doi.org/10.1007/s11695-021-05726-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-021-05726-x